PMS-METHYLPHENIDATE CR

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 2498dd2c2ed2ce00
Drug Approval Canada Name: PMS-METHYLPHENIDATE CR
Product Name: PMS-METHYLPHENIDATE CR
Status: Marketed
Status Date: 2023-10-30
Original Market Date: 2023-10-30
Din: 02536994
Drug Class: Human
Dosage Form: Capsule (Extended Release)
Route Of Administration: Oral
Schedule: Schedule G (CDSA III)
Ahfs: 28:20.32
Atc Original: N06BA04 METHYLPHENIDATE
Atc Name: n 06 ba 04
Aig Number: 0107548010
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

METHYLPHENIDATE HYDROCHLORIDE

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2498dd2c2ed2ce00

Type

Standard